Quantum Biopharma Ltd. (QNTM) stock
QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)
Close on Nov 17, 2026Market cap $6.18MP/E –Yield –
Quantum Biopharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quantum Biopharma's ebitda for the twelve months ending Jun 30, 2026 was -$11.78M. For fiscal 2025 it was -$14.76M. The highest annual figure on record is -$14.76M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.76M | – |
| FY2024 | Dec 31, 2024 | -$15.65M | – |
| FY2023 | Dec 31, 2023 | -$21.28M | – |
| FY2022 | Dec 31, 2022 | -$22.90M | – |
| FY2021 | Dec 31, 2021 | -$29.70M | – |
| FY2020 | Dec 31, 2020 | -$26.79M | – |
| FY2019 | Dec 31, 2019 | -$20.54M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.24M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.32M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.68M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.17M | – |
See a number that looks wrong?